DE69635472D1 - Impfstoff gegen Geflügelkokzidose - Google Patents

Impfstoff gegen Geflügelkokzidose

Info

Publication number
DE69635472D1
DE69635472D1 DE69635472T DE69635472T DE69635472D1 DE 69635472 D1 DE69635472 D1 DE 69635472D1 DE 69635472 T DE69635472 T DE 69635472T DE 69635472 T DE69635472 T DE 69635472T DE 69635472 D1 DE69635472 D1 DE 69635472D1
Authority
DE
Germany
Prior art keywords
proteins
vaccine against
coccidosis
poultry
against poultry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69635472T
Other languages
English (en)
Other versions
DE69635472T2 (de
Inventor
Jacobus Johannes Kok
Den Boogaart Paul Van
Arnoldus Nicolaas Vermeulen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE69635472D1 publication Critical patent/DE69635472D1/de
Publication of DE69635472T2 publication Critical patent/DE69635472T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69635472T 1995-07-03 1996-07-01 Impfstoff gegen Geflügelkokzidose Expired - Lifetime DE69635472T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95201801 1995-07-03
EP95201801 1995-07-03

Publications (2)

Publication Number Publication Date
DE69635472D1 true DE69635472D1 (de) 2005-12-29
DE69635472T2 DE69635472T2 (de) 2006-04-13

Family

ID=8220445

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69635472T Expired - Lifetime DE69635472T2 (de) 1995-07-03 1996-07-01 Impfstoff gegen Geflügelkokzidose

Country Status (12)

Country Link
US (3) US6100241A (de)
EP (1) EP0775746B1 (de)
JP (1) JP4116680B2 (de)
AT (1) ATE310747T1 (de)
AU (1) AU707350B2 (de)
CA (1) CA2180309C (de)
DE (1) DE69635472T2 (de)
DK (1) DK0775746T3 (de)
ES (1) ES2253746T3 (de)
HU (1) HUP9601809A3 (de)
NZ (1) NZ286915A (de)
ZA (1) ZA965586B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ286915A (en) * 1995-07-03 1998-03-25 Akzo Nobel Nv Protein with one or more antigenic determinants of eimeria lactate dehydrogenase, its production and use
US6680061B1 (en) * 1998-10-07 2004-01-20 Theodorus Cornelis Schaap Coccidiosis vaccines
AU2002211814A1 (en) * 2000-09-12 2002-03-26 Gen-Probe Incorporated Compositions, methods and kits for determining the presence of cryptosporidium organisms in a test sample
TWI348376B (en) 2002-02-26 2011-09-11 Wyeth Corp Selection of poultry eimeria strains through extra-intestinal sporozites
WO2004052393A1 (en) * 2002-12-09 2004-06-24 University Of Georgia Research Foundation, Inc. Coccidial vaccine and methods of making and using same
US7354593B2 (en) 2002-12-09 2008-04-08 Merial Limited Coccidial vaccine and methods of making and using same
US20050058658A1 (en) * 2003-07-15 2005-03-17 Barros Research Institute Compositions and methods for immunotherapy of human immunodeficiency virus (HIV)
US7393534B2 (en) * 2003-07-15 2008-07-01 Barros Research Institute Compositions and methods for immunotherapy of cancer and infectious diseases
US6986264B1 (en) * 2004-07-15 2006-01-17 Carrier Corporation Economized dehumidification system
EP2629794B1 (de) 2010-10-18 2017-06-07 Intervet International B.V. Durch den truthahn-herpesvirus vektorisierter impfstoff gegen vogelgrippe bei geflügel
FR3008992A1 (fr) 2013-07-25 2015-01-30 Agronomique Inst Nat Rech Procede de selection d'une lignee cellulaire permissive pour la replication de virus aviaires
RU2627612C1 (ru) * 2016-07-14 2017-08-09 ФАНО России, Федеральное государственное бюджетное научное учреждение Всероссийский научно-исследовательский институт фундаментальной и прикладной паразитологии животных и растений им. К.И. Скрябина (ФГБНУ "ВНИИП им. К.И. Скрябина") Способ профилактики и лечения ремонтного молодняка кур яичных пород при кокцидиозах
CN113248587B (zh) * 2021-05-06 2022-04-12 广东省农业科学院动物卫生研究所 用于防治堆型艾美耳球虫的重组多肽及疫苗

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1338705C (en) 1981-10-22 1996-11-12 Roy Curtiss Iii Vaccines obtained from antigenic gene products of recombinant genes
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US4769330A (en) 1981-12-24 1988-09-06 Health Research, Incorporated Modified vaccinia virus and methods for making and using the same
US4603112A (en) 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
AU570940B2 (en) 1982-11-30 1988-03-31 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Process for producing poxvirus recombinants for expression offoreign genes
US5273901A (en) * 1984-07-05 1993-12-28 Enzon Corp. Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b
WO1986006487A1 (en) 1985-04-22 1986-11-06 Commonwealth Serum Laboratories Commission Method for determining mimotopes
US4724145A (en) * 1985-11-18 1988-02-09 Merck & Co., Inc. Eimeria acervulina immunogens
DE3785404T2 (de) * 1986-08-18 1993-07-29 British Tech Group Impfstoffe.
WO1988002022A1 (en) 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
EP0351418B1 (de) 1987-03-19 1995-05-17 Synergen, Inc. Virales vektorsystem zum einführen fremder dns-expressionserzeugnisse in gallinaceenvögeln
FR2632863B2 (fr) 1987-10-29 1990-08-31 Transgene Sa Virus du fowlpox recombinant et vaccins derives de ces virus
NZ227597A (en) 1988-01-15 1991-11-26 Merck & Co Inc Eimeria tenella group b immunogens and their production
ZA893740B (en) * 1988-06-03 1990-02-28 Hoffmann La Roche Recombinant coccidiosis vaccines
ZA894726B (en) * 1988-06-27 1990-03-28 Akzo Nv Coccidiosis vaccine
EP0548252A4 (en) 1990-09-12 1995-02-15 Genex Corp Genetically engineered coccidiosis vaccine
ZA924203B (en) * 1991-06-18 1993-03-31 Akzo Nv Coccidiosis poultry vaccine
AU6627594A (en) * 1993-04-12 1994-11-08 Trustees Of Dartmouth College Gene encoding the lactate dehydrogenase enzyme of plasmodium falciparum
US5686294A (en) * 1993-07-02 1997-11-11 Toyo Boseki Kabushiki Kaisha Protein having heat-resistant malate dehydrogenase activity
NZ286915A (en) * 1995-07-03 1998-03-25 Akzo Nobel Nv Protein with one or more antigenic determinants of eimeria lactate dehydrogenase, its production and use
US6514694B2 (en) * 1997-12-19 2003-02-04 Heska Corporation Methods for the detection of encysted parasites
US7550558B2 (en) * 2001-06-01 2009-06-23 Fundacao De Ampara A Pesquiso Do Estado De Sao Paolo (Fapesp) Antimicrobial peptides and methods for identifying and using such peptides
ZA200400479B (en) * 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use
BR0210850A (pt) * 2001-07-06 2004-12-07 Biolog Lab Teva Ltd ácidos nucléicos que codificam um antìgeno de 250 kda recombinante de esporozoìtos/merozoìtos de eimeria máxima e seus usos
WO2008034121A2 (en) * 2006-09-16 2008-03-20 Board Of Regents, The University Of Texas System Parasite vaccine

Also Published As

Publication number Publication date
AU5628796A (en) 1997-01-16
HUP9601809A3 (en) 2003-08-28
US6100241A (en) 2000-08-08
EP0775746B1 (de) 2005-11-23
DE69635472T2 (de) 2006-04-13
ZA965586B (en) 1997-01-31
EP0775746A3 (de) 1997-06-11
JPH0948797A (ja) 1997-02-18
CA2180309A1 (en) 1997-01-04
JP4116680B2 (ja) 2008-07-09
US7638131B2 (en) 2009-12-29
DK0775746T3 (da) 2006-04-03
CA2180309C (en) 2009-12-22
ATE310747T1 (de) 2005-12-15
EP0775746A2 (de) 1997-05-28
AU707350B2 (en) 1999-07-08
US20080233138A1 (en) 2008-09-25
NZ286915A (en) 1998-03-25
ES2253746T3 (es) 2006-06-01
US7230075B1 (en) 2007-06-12
HUP9601809A2 (en) 1997-05-28

Similar Documents

Publication Publication Date Title
DE69225357D1 (de) Impfstoff gegen Geflügelkokzidose
DE69635472D1 (de) Impfstoff gegen Geflügelkokzidose
DE69939747D1 (de) Verfahren von dna-impfung
MX9203458A (es) Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano.
NO20014415D0 (no) Medisinske preparater til behandling av <alfa>-galaktosidase- A-defisiens
IT1206311B (it) Agente terapeutico a base di oligonucleotide e metodi per laproduzione dello stesso.
DE69432137D1 (de) Impfstoff gegen Geflügelkokzidose
DE69521007D1 (de) Impfstoff gegen Geflügelkokzidose
EA200100700A1 (ru) Гены и белки и их применение
DE69101646D1 (de) Vakzine gegen Coccidiose.
MXPA02005506A (es) Clonacion de un gen que codifica una racemasa de aminoacido derivada de tripanosoma cruzi, y usos del mismo.
ATE499383T1 (de) Eine methode zur herstellung von menschlichem natürlichem interferon-alpha
Vermeulen et al. DNA encoding an Eimeria 200 kD antigen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INTERVET INTERNATIONAL B. V., AN BOXMEER, NL